AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
SkyePharma PLC announced the acquisition of 59.8% of the outstanding voting shares of RTP Pharma Inc in return for the issue of SkyePharma Ordinary Shares to the value of $20.6 M, thereby securing ownership of the Canadian company. RTP Pharma is globally respected for its nanoparticulate technology used to improve drug solubility. On 1 Aug 2001, SkyePharma announced that it had paid $20 M in SkyePharma Ordinary Shares and acquired $5 M of Preferred …